Back to Insights
DeepTech · Innovation Funding

European Funding for DeepTech Companies: The Complete Strategy Guide

DeepTech companies face long development cycles, high capital requirements and uncertain timelines. European R&D funding is designed precisely for this profile — providing non-dilutive capital at the stages where VC is scarce.

Prepared by Paulina Złotko — Co-Founder, European Funding Agency

Strategic Advisory · 7 min read

Why DeepTech companies are the ideal European grant candidates

European grant programmes were architected to fund exactly what DeepTech companies do: long-horizon R&D with high technical uncertainty and transformative market potential. The EIC Accelerator, Eurostars, and Horizon Europe all explicitly prioritise DeepTech sectors — quantum, photonics, semiconductors, advanced materials, robotics, and biotechnology — as strategic investment areas.

For DeepTech founders, grants serve a specific purpose: they fund the "valley of death" between fundamental research and commercial product — the stage that is too late for academic grants but too early and risky for most VCs.

The EIC Accelerator: Europe's flagship DeepTech programme

The European Innovation Council Accelerator is the most powerful single instrument for DeepTech companies in Europe. It provides up to €2.5M in non-dilutive grants plus an optional equity investment of up to €15M from the EIC Fund. The programme targets "breakthrough innovations" — companies developing technology that is 10× better than existing solutions or creating entirely new market categories.

EIC Accelerator is highly competitive (5–10% final success rate) but the evaluation criteria align directly with DeepTech strengths: technical novelty, TRL progression, market disruption potential, and the team's scientific depth. DeepTech companies with patents, publications, and demonstrated TRL progression from 4 to 7 are among the strongest EIC candidates.

The EIC application process is structured in two stages: a short application (video pitch + written summary), followed by an in-person jury interview for shortlisted companies. Preparation for the jury interview is critical — the panel includes both technical experts and commercial evaluators.

Eurostars for DeepTech: the accessible international route

Eurostars is consistently one of the top-performing programmes for DeepTech SMEs. DeepTech projects at TRL 3–6 — where fundamental research is complete but commercial product development is still ongoing — are ideal Eurostars candidates. The programme rewards precisely the combination of technical depth and commercial ambition that defines successful DeepTech companies.

DeepTech sectors with the highest Eurostars success rates include: photonics and optics (consistently overrepresented in awarded projects), quantum technologies (growing rapidly), advanced manufacturing and robotics, and semiconductor design. AI-enabled hardware combinations are particularly strong.

The Eurostars partner requirement is actually an advantage for DeepTech companies. International R&D partnerships open access to complementary research capabilities, shared IP development, and commercial channels in partner countries — all while providing the consortium structure that reviewers reward.

Horizon Europe: large-scale DeepTech collaboration

Horizon Europe's Cluster 4 (Digital, Industry and Space) and Cluster 5 (Climate, Energy and Mobility) are the primary routes for DeepTech companies. Individual company budgets within Horizon consortia typically range from €500K to €3M. Horizon requires 3–7 partners including academic institutions, which makes it better suited to scale-up stage DeepTech companies with consortium-building experience.

EIC Pathfinder (a Horizon instrument) targets even earlier-stage fundamental research — TRL 1–4 — with grants of €3–4M per project. It is ideal for DeepTech companies that are still at the "proof of concept" stage for their core enabling technology.

Building the funding stack for a DeepTech company

The most effective DeepTech funding strategies combine multiple programmes sequentially and simultaneously:

  • Early stage (TRL 1–3): National grants + EIC Pathfinder for fundamental R&D
  • Mid stage (TRL 3–6): Eurostars for international collaborative R&D + national grants for domestic R&D activities
  • Commercial stage (TRL 6–8): EIC Accelerator grant + equity for market entry + Horizon Europe for continued R&D
  • Scale stage (TRL 8+): InvestEU, European Investment Fund, Horizon KIC programmes

We map this full stack for each client — identifying which programmes to pursue simultaneously (no double-funding of the same costs, but overlapping programmes for different activities is fully permitted) and which to sequence for maximum capital efficiency.

Common mistakes DeepTech companies make in grant applications

The most frequent failure modes we observe in DeepTech applications: (1) Over-technical writing that obscures commercial impact — reviewers need both; (2) Insufficient articulation of TRL progression — evaluators want to see a clear from/to narrative; (3) Underspecified work packages — vague project architecture signals execution risk; (4) Weak commercial sections — deep technical teams often underestimate how heavily commercialisation is weighted in grant evaluations.

Find Your Route

Identify the right European funding programme for your DeepTech company.